We trim our target price (TP) by 12.5% mainly due to a 12% reduction in our peer target PBV, a 100-bp upward revision in our cost of equity and downward revisions of 4.5% and 3.0% in our 2018 and 2019 earnings forecasts, respectively. We, however, maintain our BUY rating.